Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, biote Corp. reported revenue of $192M, down 2.5% year over year. Operating margin was 18.5% and net margin 14.1%, on a free-cash-flow margin of 15.7% with capital expenditure at 2.6% of revenue. Every figure is computed directly from BTMD's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $192M | 18.5% | 14.1% |
| FY2024 | $197M | 16.0% | 1.6% |
| FY2023 | $185M | 15.5% | 1.8% |
| FY2022 | $165M | -36.8% | -0.6% |
| FY2021 | $139M | 24.8% | 8.0% |
How does BTMD compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
See BTMD benchmarked against two sector peers (free) →
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.